Evercore ISI Group Maintains Outperform on Omada Health, Lowers Price Target to $15

Benzinga Newsdesk www.benzinga.com Negative 94.1%

Neg 94.1% Neu 0% Pos 0%

Evercore ISI Group analyst Elizabeth Anderson maintains Omada Health (NASDAQ:OMDA) with a Outperform and lowers the price target from $20 to $15.